AngioDynamics Announces Publication of DIRECT Study Results and New Category I CPT Code for Pancreatic IRE

AngioDynamics has published results from its DIRECT study, which assessed its irreversible electroporation (IRE) technology for pancreatic cancer treatment. The company also announced the establishment of a new Category I CPT code for pancreatic IRE procedures, which is expected to enhance billing standardization and potentially increase adoption and reimbursement for its NanoKnife system. These developments are seen as significant advancements for AngioDynamics' oncology business.